Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy - Test2 - elhamkhani - TriplyDB

Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy

Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy

http://www.wikidata.org/entity/Q24650612

about

Pseudomonas aeruginosa biofilms in cystic fibrosis A Lipid Mediator Hepoxilin A3 Is a Natural Inducer of Neutrophil Extracellular Traps in Human Neutrophils Why is Pseudomonas aeruginosa a pathogen?Polyelectrolyte properties of filamentous biopolymers and their consequences in biological fluids.Antimicrobial Efficacy of Contact Lens Care Solutions Against Neutrophil-Enhanced Bacterial Biofilms.Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.Pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit model Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media--a potential treatment target Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.Disruption of contact lens-associated Pseudomonas aeruginosa biofilms formed in the presence of neutrophils.Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.Polyelectrolyte-mediated increase of biofilm mass formation.Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.The exopolysaccharide Psl-eDNA interaction enables the formation of a biofilm skeleton in Pseudomonas aeruginosa.Innate Immune Signaling Activated by MDR Bacteria in the Airway Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.Biofilm matrix and its regulation in Pseudomonas aeruginosa.Mycobacterium avium biofilm attenuates mononuclear phagocyte function by triggering hyperstimulation and apoptosis during early infection.Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis.The immune system vs. Pseudomonas aeruginosa biofilms.Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.The effects of silicone hydrogel lens wear on the corneal epithelium and risk for microbial keratitis.The granuloma in tuberculosis: dynamics of a host-pathogen collusion.Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells.Biofilms and host response - helpful or harmful.A Critical Role for Extracellular DNA in Dental Plaque Formation.Extracellular DNA and F-actin as targets in antibiofilm cystic fibrosis therapy.Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms.NET balancing: a problem in inflammatory lung diseases.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics.Acceleration of the formation of biofilms on contact lens surfaces in the presence of neutrophil-derived cellular debris is conserved across multiple genera.Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.Host Defence against Bacterial Biofilms: “Mission Impossible”?Characterization of eDNA from the clinical strain Acinetobacter baumannii AIIMS 7 and its role in biofilm formation

P2860

Q28299966-7F347209-8E5C-4B02-9EB9-AF70D58E2CF9 Q29013771-7875A81C-17DD-4E96-87C2-AD1C466F6BDD Q30434529-5FD9F3D8-0100-4925-918D-F40A6920D514 Q33563964-08289515-E681-48DC-833A-E3E17BA7650B Q33626325-9A9D1294-5F85-4D2D-947E-C9765A91888B Q34016539-65E150A7-FE92-4FA3-816E-CA3F6852958A Q34211398-98986430-07BA-4130-BC94-67D70CFC9D26 Q34580853-C9654ACF-53AE-4FA2-8F34-726E13DE0B72 Q34596738-8987EB9B-4C3B-48D6-861D-13D80210B08D Q34603485-66C94423-13D7-431E-B853-8881BB32FC90 Q34937175-FB3B7E0D-DEF6-4153-8209-45157A89D9BE Q35180731-9BF7CD78-FD6A-402D-85B8-68BF0F636B58 Q35654991-C9754F11-8808-4F4D-972F-16556CD1239F Q35782697-57C77D81-B310-4870-AD54-736EDF48E8C6 Q36055572-711B75E5-3A3E-4F64-BF4C-CE6398627510 Q36307388-E8D9D495-921F-4B33-AB0D-D2EB26B757BD Q36422470-0D587B4B-49CB-4336-ABF0-C8508BC84745 Q37018035-57840200-B2A1-4F46-B162-CCF33203E3D3 Q37291396-E0296249-CF7C-4F0E-901E-66F5A286E48D Q37548070-7701673B-5FC1-4EB6-A886-0510B4814D99 Q37548115-5071F172-B6E3-4FEE-8C07-54C33849243D Q37727995-51238303-8CAF-4517-8719-BA9108F230A6 Q37767747-8C06700A-D023-4552-B6F1-1493E05A9611 Q37849777-ABF26A5C-AE51-44EA-850A-330B01E8B8E0 Q38069767-B8640338-0EE2-4271-8706-B2402D0CAEF6 Q38073249-F6B3CB0B-65D6-4024-B24E-58F53A786D02 Q38268531-8A2D6A6E-A985-4149-84F2-7F3CC32C6831 Q38835228-68F2A939-F5B0-4E0B-A20B-B41C665423A1 Q39240791-A1DC17EB-7496-4206-AA3D-883002AB7E76 Q39260148-01519724-941B-4B55-B7C5-C5D7AA3F9703 Q39957550-74EFF72B-3B93-4D09-AD75-EB0D263C5E24 Q40622669-E26C9336-3F00-47C6-9BA9-FC4E55C916EB Q42947423-B78E8396-3FD0-4054-A794-ADD50A0CED68 Q47730320-4BE61166-C64C-4682-B15C-7C9607BAEB13 Q49387443-8EB67E33-FF6E-4DCD-9D5A-8EF3F03AB6E3 Q50106512-6375CEBC-6B21-4AE7-BA43-439230B42D46 Q51736541-1873B9B4-2641-427F-9289-0E9BA039A36B Q54205022-39462660-BDBF-4DF1-9997-F970D8338331 Q58692848-5920C379-3E06-4C40-BEF1-D2E1F73AAF0B Q58915158-B51D9D24-7DAF-4EF3-813A-E6C0157F0323

P2860

Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy

http://www.wikidata.org/entity/Q24650612

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@ast

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@en

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@nl

type

label

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@ast

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@en

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@nl

prefLabel

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@ast

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@en

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@nl

P1433

Q24650612-AE8A1235-69C7-4F41-A5FD-271B5BDD10AD

P1476

Q24650612-E48A89DA-0F37-4C91-A84D-BFDBF3AC1F7C

P2093

Q24650612-37F91597-C27C-41F5-9DCC-7423192650D8

Q24650612-453804EE-6859-488E-B8D6-BDAF66FC2BF4

Q24650612-5800B44E-7CD5-48C9-A92F-FD14D25A8D93

Q24650612-86550D49-60E2-4C26-AB3F-2A25A1240291

Q24650612-8AE36CB0-D225-4E1B-BB7F-BF686DBFCC2B

Q24650612-ACF7B895-55BE-4603-8F70-0567E4A5060B

P2860

Q24650612-003E9917-0D43-427F-AA5D-3A8ABEC237D0

Q24650612-00B25659-18EE-4773-9B15-19B4B54FF5E2

Q24650612-0988D34E-4ABC-4E0B-B40B-88BA0E43B773

Q24650612-1752FC93-B24A-475F-B790-34DAF5D8EB5B

Q24650612-17613146-1D4A-41E9-9D71-637E04B1278C

Q24650612-1AF38E43-225B-4FA1-AF5C-4AD5DC75BBCD

Q24650612-21E9518D-E4F8-4417-8EA0-FB68251512A6

Q24650612-28EEA32B-4DAA-4F82-9776-DE970A081CC6

Q24650612-2A52C1CE-B834-48A3-8C94-71E891E1A072

Q24650612-2B2A67B9-CB3B-414E-9972-EF8DF5B13BA4

P304

Q24650612-CB942B1E-F56A-462D-A6F1-AD9222252786

P31

Q24650612-6C7EC108-F89A-43BC-BD48-553C2B1F92F1

P3181

Q24650612-B3095136-AD77-4D37-A982-B9B32DE17359

P356

Q24650612-F27CD577-34CD-4CA9-855B-C772F79CD12D

P407

Q24650612-BB1DB8B7-542A-4584-8BAA-91F387220A1E

P433

Q24650612-54F6C183-A958-4B40-9BF2-D407AF2BBC52

P478

Q24650612-CAE61DE2-09FC-480C-BAE2-B278BCBFB267

P577

Q24650612-0725B34C-3039-4075-A0A3-CC6435425308

P5875

Q24650612-8001C290-7F0A-42CF-81A1-9A80C282C41E

P698

Q24650612-D5B55285-F55E-4DF7-8D86-C20E099B9383

P921

Q24650612-337C7725-7BA1-4A9B-AD3D-80072277716A

Q24650612-73DC0A95-C574-4708-A67C-62E1909051A7

P932

Q24650612-8EE5EA97-A8DB-4DCC-A45D-8E94B911E0F3

P3181

P356

P1433

Journal of Medical Microbiology

P1476

Neutrophil enhancement of Pseu ...... and DNA as targets for therapy

@en

P2093

Jerry A Nick

http://www.w3.org/2001/XMLSchema#string

Katie R Poch

http://www.w3.org/2001/XMLSchema#string

Kenneth C Malcolm

http://www.w3.org/2001/XMLSchema#string

Michael L Vasil

http://www.w3.org/2001/XMLSchema#string

Quinn M Parks

http://www.w3.org/2001/XMLSchema#string

Robert L Young

http://www.w3.org/2001/XMLSchema#string

P2860

Extracellular DNA Required for Bacterial Biofilm Formation

Bacterial biofilms: a common cause of persistent infections

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants.

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.

Method of evaluating effects of antibiotics on bacterial biofilm.

Pathophysiology and management of pulmonary infections in cystic fibrosis.

Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease.

P304

492-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

701927

http://www.w3.org/2001/XMLSchema#string

P356

10.1099/JMM.0.005728-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 4

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24188959

http://www.w3.org/2001/XMLSchema#string

P698

19273646

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

2677169

http://www.w3.org/2001/XMLSchema#string